Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Better policies will lower drug prices

  • Ait-Allah Mejri
    Ait-Allah Mejri

    Public health physician and president director of PT Roche Indonesia

Jakarta   /   Thu, October 19, 2017   /  12:27 pm
Better policies will lower drug prices In Indonesia, there has long been a policy to prioritize domestic production of generic medicines but things didn’t work out as planned. (Shutterstock/Vinogradov Illya)

As the government resolutely pursues its commitment to ensure that universal health coverage (UHC) is achieved by 2019, there’s a debate raging on the need to develop home-grown production of active pharmaceutical ingredients (API). The aim is to reduce raw material dependence on import and curb the high-cost of prescription medicines. With the continuous deficit of the Social Security Management Agency (BPJS) and the approaching 2019 presidential election, the API production debate is gaining a new political momentum. In any country, the value added from generic manufacturers consists in introducing competition, which in an efficient market can help the government to achieve savings on older treatments and increase investment in new ones or offer lower cost alternatives to out-of-pocket patients. In Indonesia, there has long been a policy to prioritize domestic production...

Disclaimer: The opinions expressed in this article are those of the author and do not reflect the official stance of The Jakarta Post.